M. Gentil Et Al. , "Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)," PLOS ONE , vol.13, no.8, 2018
Gentil, M. Et Al. 2018. Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML). PLOS ONE , vol.13, no.8 .
Gentil, M., Hugues, P., Desterke, C., Telliam, G., Sloma, I., Souza, L. E. B., ... Baykal, S.(2018). Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML). PLOS ONE , vol.13, no.8.
Gentil, Melanie Et Al. "Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)," PLOS ONE , vol.13, no.8, 2018
Gentil, Melanie Et Al. "Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)." PLOS ONE , vol.13, no.8, 2018
Gentil, M. Et Al. (2018) . "Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)." PLOS ONE , vol.13, no.8.
@article{article, author={Melanie Gentil Et Al. }, title={Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)}, journal={PLOS ONE}, year=2018}